Back to News Page
Jennifer Holmes, CEO of PrecisionCare AI, shares how data-driven innovation is transforming musculoskeletal therapy—bringing measurable precision, real-time insights, and improved outcomes to rehabilitation.
A conversation with Arden Sorge on how Boomerang Ventures helps healthcare founders translate innovation into compelling investment opportunities through storytelling, strategy, and strong capital relationships.
10 leaders across the Boomerang Ventures portfolio are building companies that are redefining connected health. From digital therapeutics and musculoskeletal care to AI-driven metabolic monitoring and respiratory wellness, these innovators are tackling some of healthcare’s most complex challenges while developing scalable, data-driven solutions. This introductory feature highlights the leaders behind these companies and sets the stage for an upcoming series of individual Q&A profiles exploring their vision, leadership, and impact.
Source: The Journal of Clinical Psychiatry
Mentavi Health, a Portfolio Company of Boomerang Ventures, is the lead author of a groundbreaking study published in the Journal of Clinical Psychiatry, “Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care.” The research validates the accuracy of Mentavi’s online ADHD assessment in a real-world sample of adults seeking web-based mental healthcare. Findings demonstrate strong diagnostic agreement with clinician-led interviews and highlight the tool’s high positive predictive value, providing a clinically reliable and scalable solution to expand access to ADHD evaluation.
Source: Business Insider
After sending 500 cold emails, Tejas Vijh found the rare combination of a U.S. venture capital firm willing to sponsor his visa and genuinely support his journey as an immigrant. While many international students gravitate toward Big Tech for perceived stability, Vijh found greater security, mentorship, and long-term opportunity at a small VC firm that valued his commitment and potential.
By: Tejas Vijh, Investment Team Member, Boomerang Ventures
AI is not replacing human insight in venture capital—it’s enhancing it. From deal sourcing and due diligence to portfolio management and trendspotting, AI tools like Affinity, PitchBook, and ChatGPT are reshaping how investors operate. By streamlining workflows, mitigating bias, and offering predictive insights, AI empowers firms to make smarter, data-driven decisions.
“GEOH’s mission is to help home care agencies grow and become more profitable, streamlining processes, reducing paperwork, and ensuring regulatory compliance.”
“Pelvital is a women’s health medical device company. We often call ourselves a FemTech sector company, and we’re best known by our product name, Flyte. Flyte is a novel FDA-cleared treatment for female urinary incontinence.”
As the managing partner of Boomerang Ventures, an early-stage health tech venture capital fund based in Indianapolis, I find the article “Why Innovators Are Racing to Indiana to Build Their Businesses” from Fast Company very relevant. It underscores the burgeoning innovation ecosystem in the Midwest, particularly in Indiana, aligning perfectly with our focus on investing in transformative health tech companies in this region.
Back to News Page
